Results for tag: "Vosevi"

Vosevi is a prescription medication used to treat chronic hepatitis C virus (HCV) infection in adults. It is a combination of sofosbuvir, velpatasvir, and voxilaprevir, three antiviral drugs that work together to stop the virus from multiplying in the body. Vosevi is used to treat adults with HCV genotypes 1-6, and is the only approved treatment for those with genotype 2 or 3. It is also used to treat adults who have previously been treated with an HCV regimen containing sofosbuvir, but who have not achieved a sustained virologic response. Vosevi is part of a larger market of drugs used to treat liver and kidney disorders. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, and kidney failure. Other drugs in this market include antivirals, immunosuppressants, and antifibrotics. Companies in the Vosevi market include Gilead Sciences, AbbVie, Merck, and Bristol-Myers Squibb. Show Less Read more